Liu Ying, Chen Jiao
Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Front Aging Neurosci. 2024 Aug 2;16:1423725. doi: 10.3389/fnagi.2024.1423725. eCollection 2024.
Alzheimer's disease (AD) is a common neurodegenerative disease, which can lead to cognitive impairment and dementia. Since AD is tightly associated with aging and cellular senescence, objective of this study was to investigate the association between senescence-related genes and proteins (SRGs and SRPs) and the development of AD.
The whole study was based on transcriptomic analysis of control and AD brain tissues and Mendelian randomization (MR) analysis.
For transcriptomic analysis, GSE5281 dataset from GEO database contains the transcriptomic data of human brain tissues ( = 161) from control group and AD patients. The expression of SRGs in control and AD brain tissues were compared by Student's t test. For MR analysis, the instrumental single-nucleotide polymorphisms (SNPs) associated with 110 SRPs were filtered and selected from a large genome-wide association study (GWAS) for plasma proteome. The causality between plasma levels of SRPs and AD was explored using GWAS data of AD from Lambert et al. (17,008 cases and 37,154 controls) and further validated by using data from FinnGen consortium (6,489 patients and 170,489 controls). MR estimate was performed using the inverse-variance weighted (IVW) method and the heterogeneity and pleiotropy of results were tested.
Transcriptomic analysis identified 36 up-regulated (including ) and 8 down-regulated SRGs in AD brain tissues. In addition, the MR results at both discovery and validation stages supported the causality between plasma levels of PLAUR (IVW- = 3.04E-2, odds ratio [OR] = 1.15), CD55 (IVW- = 1.56E-3, OR = 0.86), and SERPINE2 (IVW- = 2.74E-2, OR = 0.91) and the risk of AD.
Our findings identified that , as an SRG, may take part in the development of AD and found that high plasma levels of PLAUR was associated with increased risk of AD, indicating that this gene was a risk factor for this disease and providing the rationale of existing drugs or new preventative and therapeutic strategies.
阿尔茨海默病(AD)是一种常见的神经退行性疾病,可导致认知障碍和痴呆。由于AD与衰老和细胞衰老密切相关,本研究的目的是探讨衰老相关基因和蛋白质(SRGs和SRPs)与AD发生发展之间的关联。
整个研究基于对照和AD脑组织的转录组分析以及孟德尔随机化(MR)分析。
对于转录组分析,来自GEO数据库的GSE5281数据集包含对照组和AD患者的人类脑组织(n = 161)的转录组数据。通过学生t检验比较对照组和AD脑组织中SRGs的表达。对于MR分析,从一项针对血浆蛋白质组的大型全基因组关联研究(GWAS)中筛选并选择与110种SRPs相关的工具单核苷酸多态性(SNPs)。使用来自Lambert等人的AD的GWAS数据(17,008例病例和37,154例对照)探讨血浆中SRPs水平与AD之间的因果关系,并使用FinnGen联盟的数据(6,489例患者和170,489例对照)进一步验证。使用逆方差加权(IVW)方法进行MR估计,并测试结果的异质性和多效性。
转录组分析在AD脑组织中鉴定出36个上调(包括)和8个下调的SRGs。此外,发现阶段和验证阶段的MR结果均支持血浆中PLAUR(IVW - p = 3.04E - 2,比值比[OR] = 1.15)、CD55(IVW - p = 1.56E - 3,OR = 0.86)和SERPINE2(IVW - p = 2.74E - 2,OR = 0.91)水平与AD风险之间的因果关系。
我们的研究结果确定,作为一种SRG,[此处原文缺失具体基因名]可能参与AD的发生发展,并发现血浆中PLAUR水平升高与AD风险增加相关,表明该基因是这种疾病的一个危险因素,并为现有药物或新的预防和治疗策略提供了理论依据。